Fabryn Tauti
Artikkelit

Fabry disease
Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).

Cardiac involvement in Fabry disease
Cardiovascular disease is the leading cause of death in fabry disease patients.1 Undiagnosed and untreated Fabry disease leads to progressive, irreversible, life-threatening heart injury.2,3

Renal involvement in Fabry disease
Think Fabry, think renal involvement that may present early in life and could go undetected.

When to treat
Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.1,2
Koulutus

A heart for Fabry - Podcast
A podcast series designed by cardiologists, for cardiologists and other healthcare professionals.
Leave site modal
Olet poistumassa Sivustolta campus.sanofi/fi. Sanofi ei ole vastuussa tämän ulkoisen verkkoSivuston sisällöstä.
Työskenteletkö terveydenhuollossa?
Työskenteletkö terveydenhuollossa?
Tämä sivusto on suunnattu terveydenhuollon ammattilaisille. Vahvista valinta päästäksesi näkemään sisältöjä kuten videoita, podcasteja ja muita materiaaleja.